Studies of the prevalence of hormone receptor status; ER/PR/HER2 in breast cancer from Sub Saharan Africa (SSA) are fraught with inconsistencies. There are multitude of reasons for these inconsistencies but the most prominent are inadequate breast biopsy material, small sample sizes, poor histopathology services and suboptimal handling of specimens. As an example, ER/PR/HER2 receptors for breast cancers are not part of the routine assessment for breast cancer and testing is only available in a couple of centers across the entire country. Variability in Radiology, Surgery and laboratory methodology and interpretation makes comparison between data difficult. Available data shows a huge variability in the prevalence of TNBC within the sub-Sah...
INTRODUCTION: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (T...
Introduction: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (T...
Background: Triple negative breast cancers (TNBC) are defined by absence of estrogen and progesteron...
Background: Previous sub classification of breast cancer in Kenya has been fraught by small sample s...
Objectives: Studies on ER/PR/HER2 in breast cancer from Sub Saharan Africa (SSA) are fraught with in...
Background: An analysis of 322 cases referred to Aga Khan University, Nairobi, revealed 56% estrogen...
Background: Triple negative breast cancer (TNBC) is associated with different ethnic groups in the U...
Interest in identifying populations with triple negative (TN) and basal-like breast cancer stems fro...
BACKGROUND: Triple negative breast cancer (TNBC) is associated with different ethnic groups in the U...
Background: Eighty percent of women diagnosed with breast cancer (BC) in East Africa present with ad...
Background: Breast cancer is the most common malignancy accounting for 25% of all cancers in females...
INTRODUCTION: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (T...
Introduction: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (T...
Background: Triple negative breast cancers (TNBC) are defined by absence of estrogen and progesteron...
Background: Previous sub classification of breast cancer in Kenya has been fraught by small sample s...
Objectives: Studies on ER/PR/HER2 in breast cancer from Sub Saharan Africa (SSA) are fraught with in...
Background: An analysis of 322 cases referred to Aga Khan University, Nairobi, revealed 56% estrogen...
Background: Triple negative breast cancer (TNBC) is associated with different ethnic groups in the U...
Interest in identifying populations with triple negative (TN) and basal-like breast cancer stems fro...
BACKGROUND: Triple negative breast cancer (TNBC) is associated with different ethnic groups in the U...
Background: Eighty percent of women diagnosed with breast cancer (BC) in East Africa present with ad...
Background: Breast cancer is the most common malignancy accounting for 25% of all cancers in females...
INTRODUCTION: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (T...
Introduction: Estimates of the proportion of estrogen receptor negative (ERN) and triple-negative (T...
Background: Triple negative breast cancers (TNBC) are defined by absence of estrogen and progesteron...